Updated
Vor BiopharmaVOR · Healthcare
$19.88+6.54%
Market cap$1.2B
IndustryBiotechnology
Vor Biopharma (VOR) Superinvestor holders
8 of the superinvestors we track hold Vor Biopharma (VOR) in their latest 13F filings, $21M in total.
Summary
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $16M, 0.9% of the portfolio.
In their latest quarter: 4 opened a new position, 3 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Wilmot Harkey Nantahala Capital Management |
New position | 845,000 | $16M | 0.9% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 95,643 | $2M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
New position | 54,671 | $1M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
New position | 37,012 | $681,391 | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 33,011 | $607,733 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
New position | 28,057 | $533,000 | 0.0% | Q3 2026 |
| Alex Denner Sarissa Capital Management |
Held | 25,399 | $467,596 | 0.3% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 19,620 | $361,204 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 7 |
| Q1 2026 | 6 |
| Q4 2025 | 2 |
| Q3 2025 | 2 |
| Q2 2025 | 3 |
| Q1 2025 | 4 |
| Q4 2024 | 6 |
| Q3 2024 | 6 |
Questions about Vor Biopharma
Which superinvestors own Vor Biopharma?
8 of the superinvestors we track hold Vor Biopharma (VOR) in their latest 13F filings, $21M in total. Wilmot Harkey, Paul Marshall, David Shaw, Two Sigma, Jim Simons, Acadian.
Who is the largest superinvestor holder of VOR?
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $16M, 0.9% of the portfolio.
From Vor Biopharma's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.